Our speakers shared insights on the recent announcement of the new TDS rule.
Our speakers also discussed the following aspects:
- Provisions of section 194R introduced by the Finance Act, 2022
- Implications of the CDBT Circular No. 12/ 2022 dated 16 June 2022 including:
- Dealer conferences/trips
- Free medical samples
- Discounts, rebates, cash benefits
- Benefits to directors/employees
- Valuation of benefits and perquisites
- Compliance – non-cash perquisites
- Implementation and operational challenges likely to be faced by the industry
Speakers
- Sameer Gupta – Tax Markets Leader, EY India
- Hitesh Sharma – Partner, International Tax and Transaction Services and Tax Life Sciences Leader, EY India
- Amresh Choudhary – Group Tax Head, Alembic Pharmaceuticals Ltd
- Vikas Aggarwal – Direct Tax Head, Novartis
- Ravikant Kamath – Associate Tax Partner, Knowledge and Solutions, EY India
Moderator
- Rajan Vora – Tax Controversy Leader, Indian member firm of EY Global
Webcast
Time your local time